ERBB2 and breast carcinoma: Unsupervised clustering of breast tumor samples based on high-throughput expression profiles enabled the identification of HER2+ breast cancer subtype (Carey et al., 2006; Wirapati et al., 2008; Onitilo et al., 2009).